Guggenheim Assumes Nanobiotix at Buy, Announces Price Target of $64
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsInitiationPrice Target
Guggenheim analyst Paul Jeng assumes Nanobiotix (NASDAQ:NBTX) with a Buy rating and announces Price Target of $64.
Guggenheim analyst Paul Jeng assumes Nanobiotix (NASDAQ:NBTX) with a Buy rating and announces Price Target of $64.